✦ LIBER ✦

Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials

✍ Scribed by Cheuk-Kit Wong; L. Kristin Newby; Manju V. Bhapker; Phil E. Aylward; Matthias Pfisterer; Karen P. Alexander; Paul W. Armstrong; Judith S. Hochman; Frans Van de Werf; Robert M. Califf; Harvey D. White

Book ID: 116190994
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 123 KB
Volume: 154
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2007.04.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and management of hypertensio

Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials

✍ Camille G. Frazier; Svati H. Shah; Paul W. Armstrong; Manjushri V. Bhapkar; Darr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Long-term oral platelet glycoprotein IIb

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trial

✍ L.Kristin Newby 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 96 KB